(Q30510167)

10 August 2017

Phosphorylated α-synuclein in Parkinson's disease (English)

1 reference

10 August 2017

1 reference

0 references

1 reference

4

1 reference

PubMed publication ID

22 June 2017

8

John Q Trojanowski

1 reference

10 August 2017

6

Daniela Berg

2 references

ORCID Public Data File 2021

10 August 2017

Irene Litvan

12

object named as

Irene Litvan

1 reference

10 August 2017

24

Jing Zhang

1 reference

10 August 2017

0 references

19

Douglas Galasko

1 reference

10 August 2017

14

Elaine R Peskind

1 reference

10 August 2017

Yu Wang

1

1 reference

10 August 2017

Min Shi

2

1 reference

10 August 2017

Kathryn A Chung

3

1 reference

10 August 2017

James B Leverenz

5

1 reference

10 August 2017

Karin Srulijes

7

1 reference

10 August 2017

Virginia M-Y Lee

9

1 reference

10 August 2017

Andrew D Siderowf

10

1 reference

10 August 2017

Howard Hurtig

11

1 reference

10 August 2017

Mya C Schiess

13

1 reference

10 August 2017

Masami Masuda

15

1 reference

10 August 2017

Masato Hasegawa

16

1 reference

10 August 2017

Xiangmin Lin

17

1 reference

10 August 2017

Catherine Pan

18

1 reference

10 August 2017

David S Goldstein

20

1 reference

10 August 2017

Poul Henning Jensen

21

1 reference

10 August 2017

Hui Yang

22

1 reference

10 August 2017

Kevin C Cain

23

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

Science Translational Medicine

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

121

1 reference

10 August 2017

121ra20

1 reference

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Neuropathology of variants of progressive supranuclear palsy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Second consensus statement on the diagnosis of multiple system atrophy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

alpha-Synuclein is phosphorylated in synucleinopathy lesions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Consensus statement on the diagnosis of multiple system atrophy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Alpha-synuclein in Lewy bodies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302662

Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease

20 June 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002566

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002566

The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002566

Ultra-high field NMR studies of antibody binding and site-specific phosphorylation of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002566

In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22344688

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1126/SCITRANSLMED.3002566

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

22344688

1 reference